new glp-1 drug retatrutide for weight loss: Study shows 30% body weight loss Demand for Unapproved Weight-Loss Drug
Description
While this signal reached weak statistical significance when stratifying the follow-up into early and late phases, such findings must be interpreted with caution
The biological plausibility is strong
There is no specific additional muscle loss with these compounds, but there is the loss of lean body mass associated with the weight loss
For the 62 million Spanish-speaking Americans, this is not a minor feature
We have also heard of women who lost weight only to have their insurance company discontinue coverage
